Stock Research: Divi's Laboratories

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Divi's Laboratories

NSI:DIVISLAB INE361B01024
19
  • Value
    9
  • Growth
    77
  • Safety
    Safety
    99
  • Combined
    37
  • Sentiment
    56
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Divi's Laboratories Limited is an India-based company engaged in pharmaceutical ingredients, intermediates, and nutraceutical ingredients with a focus on exports and custom synthesis. Its main businesses include manufacturing active pharmaceutical ingredients (APIs) and intermediates, and providing contract manufacturing services for global innovator companies across various therapeutic areas. The company operates in India and has subsidiaries in the USA and Europe. In the last fiscal year, the company had a market cap of $21095 million, profits of $587 million, revenue of $1095 million, and 18300 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
9 5 11 15
Growth
77 81 43 81
Safety
Safety
99 99 100 100
Sentiment
56 67 49 6
360° View
360° View
19 19 59 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
26 7 1 27
Opinions Change
49 94 50 17
Pro Holdings
n/a 81 73 40
Market Pulse
77 60 64 55
Sentiment
56 67 49 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
9 5 11 15
Growth
77 81 43 81
Safety Safety
99 99 100 100
Combined
37 37 55 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
3 1 5 3
Price vs. Earnings (P/E)
5 5 12 22
Price vs. Book (P/B)
10 14 28 20
Dividend Yield
45 31 39 44
Value
9 5 11 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
93 84 74 76
Profit Growth
73 74 34 63
Capital Growth
30 14 50 70
Stock Returns
59 99 37 65
Growth
77 81 43 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
97 100 96 100
Refinancing
22 42 50 40
Liquidity
100 100 98 100
Safety Safety
99 99 100 100

Similar Stocks

Discover high‑ranked alternatives to Divi's Laboratories and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: